New Biotech-Academia Partnership Approaches to Empower the Drug Development Ecosystem
As alternative funding pathways decrease and fewer research grants are administered, the relationship between biotech and academia must shift in order to continue to achieve innovation and development. In this podcast, featuring a panel discussion from the 2026 Chief Medical Officer Summit 360°, CMOs and academics present on these shifts in the global clinical development ecosystem, and how academia and biotech can better partner to develop new therapies for patients, with specific examples.To learn more about the Chief Medical Officer Summit 360°, please visit CMOSummit360.com.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from PharmaTalkRadio
What’s Next in Immuno-Oncology - A Visionary Conversation with Dr Ira Mellman
Developing a Global Clinical Trial Strategy for Emerging Biotechs
How Pharma Teams Evaluate Biotech Companies for Partnerships and Acquisitions
What to Expect at Partnerships with Sites 2026
Get summaries like this every morning.
Free AI-powered recaps of PharmaTalkRadio and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.